Orthogon Therapeutics Is A Biotechnology Company Based In Cantonmassachusettsestablished In 2012The Company Specializes In Developing Innovative Antiviral Drugsfocusing On Small Molecules That Target Challenging Drug Targetsorthogon Aims To Connect Frontier Research With Formal Drug Developmentparticularly In The Antiviral Space The Company S Product Pipeline Includes A First In Class Oral Therapy For Bk Polyomaviruswhich Is Significant For Transplant Patientsadditionallyorthogon Is Working On Pan Coronavirus Inhibitors And Exploring Treatments For Gram Negative Bacterial Infectionsboth Currently In The Discovery Phasewith Over $25 Million In Fundingincluding A Recent $5 2 Million Financing Roundorthogon Is Well Positioned To Advance Its Research And Development Efforts In Antiviral Therapeuticsthe Leadership Teamled By Ceo Drali Hmunawaris Committed To Rigorous Scientific Research To Drive The Company S Innovative Projects Forward
No conferences found for this company.
| Company Name | Orthogon Therapeutics Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
